Emc Capital Management Intra Cellular Therapies, Inc. Transaction History

Emc Capital Management

  • $152 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$38.74 - $62.09 $763,100 - $1.22 Million
-19,698 Closed
0 $0
Q2 2021

Aug 09, 2021
SELL
$29.3 - $44.5 $100,938 - $153,302
-3,445 Reduced 14.89%
19,698 $804,000
Q1 2021

May 05, 2021
SELL
$30.8 - $39.51 $83,314 - $106,874
-2,705 Reduced 10.47%
23,143 $785,000
Q4 2020

Feb 24, 2021
BUY
$23.34 - $32.22 $603,292 - $832,822
25,848 New
25,848 $822,000

Others Institutions Holding ITCI

# of Institutions
377
Shares Held
84.1M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.88B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Emc Capital Management Portfolio

Follow Emc Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emc Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Emc Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email